Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population-Reference-Cited by-同舟云学术

Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population

Published:2014-05-16 Issue:5 Volume:9 Page:e97262
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

López-Cortés Luis F.,Viciana Pompeyo,Girón-González José A.,Romero-Palacios Alberto,Márquez-Solero Manuel,Martinez-Perez Maria A.,López-Ruz Miguel A.,de la Torre-Lima Javier,Téllez-Pérez Francisco,Delgado-Fernández Marcial,Garcia-Lázaro Milagros,Lozano Fernando,Mohamed-Balghata Mohamed O.,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference22 articles.

1. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1. Antimicrob Agents Chemother;K Andries,2004

2. An open-label assessment of TMC 125 - a new, next-generation NNRTI, for 7 days in HIV-1 infected individuals with NNRTI resistance. AIDS;BG Gazzard,2003

3. A randomized, double-blind, placebo-controlled trial of TMC125 as 7-day monotherapy in antiretroviral naive, HIV-1 infected subjects;B Gruzdev,2009

4. Efficacy and safety of Etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials. AIDS;C Katlama,2009

5. Efficacy and safety of Etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials. Antivir Ther;C Katlama,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial;SAGE Open Medicine;2017-01-18

2. Therapy-Emergent Drug Resistance to Integrase Strand Transfer Inhibitors in HIV-1 Patients: A Subgroup Meta-Analysis of Clinical Trials;PLOS ONE;2016-08-17

3. Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients;Infectious Diseases;2016-01-13

4. Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis;HIV Medicine;2015-06-30